Larvol Delta - Clinical-Trial-for-Autologus-NK-Cells-Alone-or-in-Combination-With-Isatuximab-as-Maintenance-for-Multiple-Myeloma

CellProtect (evencaleucel) - Avaris, XNK Therap

Sarclisa (isatuximab-irfc) - Sanofi

http://clinicaltrials.gov/ct2/show/NCT04558931

Aug 16, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next